| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | NVP-231 | CTRPv2 | pan-cancer | AAC | 0.039 | 0.2 |
| mRNA | parbendazole | CTRPv2 | pan-cancer | AAC | 0.037 | 0.2 |
| mRNA | myricetin | CTRPv2 | pan-cancer | AAC | 0.045 | 0.2 |
| mRNA | AC55649 | CTRPv2 | pan-cancer | AAC | -0.045 | 0.2 |
| mRNA | tretinoin:navitoclax (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.041 | 0.2 |
| mRNA | BRD-K97651142 | CTRPv2 | pan-cancer | AAC | -0.044 | 0.2 |
| mRNA | SB-431542 | CTRPv2 | pan-cancer | AAC | -0.044 | 0.2 |
| mRNA | TGX221 | CTRPv2 | pan-cancer | AAC | 0.044 | 0.2 |
| mRNA | marinopyrrole A | CTRPv2 | pan-cancer | AAC | -0.051 | 0.2 |
| mRNA | 968 | CTRPv2 | pan-cancer | AAC | 0.083 | 0.2 |